One Thing To Remember About The Fulgent Genetics, Inc. (NASDAQ:FLGT) Share Price

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

If you own shares in Fulgent Genetics, Inc. (NASDAQ:FLGT) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of volatility. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The second sort is caused by the natural volatility of markets, overall. For example, certain macroeconomic events will impact (virtually) all stocks on the market.

Some stocks see their prices move in concert with the market. Others tend towards stronger, gentler or unrelated price movements. Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). However, Warren Buffett said ‘volatility is far from synonymous with risk’ in his 2014 letter to investors. So, while useful, beta is not the only metric to consider. To use beta as an investor, you must first understand that the overall market has a beta of one. Any stock with a beta of greater than one is considered more volatile than the market, while those with a beta below one are either less volatile or poorly correlated with the market.

Check out our latest analysis for Fulgent Genetics

What FLGT’s beta value tells investors

Given that it has a beta of 1.42, we can surmise that the Fulgent Genetics share price has been fairly sensitive to market volatility (over the last 5 years). Based on this history, investors should be aware that Fulgent Genetics are likely to rise strongly in times of greed, but sell off in times of fear. Many would argue that beta is useful in position sizing, but fundamental metrics such as revenue and earnings are more important overall. You can see Fulgent Genetics’s revenue and earnings in the image below.

NasdaqGM:FLGT Income Statement, June 19th 2019
NasdaqGM:FLGT Income Statement, June 19th 2019

Does FLGT’s size influence the expected beta?

With a market capitalisation of US$107m, Fulgent Genetics is a very small company by global standards. It is quite likely to be unknown to most investors. It takes less money to influence the share price of a very small company. This may explain the excess volatility implied by this beta value.

What this means for you:

Since Fulgent Genetics has a reasonably high beta, it’s worth considering why it is so heavily influenced by broader market sentiment. For example, it might be a high growth stock or have a lot of operating leverage in its business model. In order to fully understand whether FLGT is a good investment for you, we also need to consider important company-specific fundamentals such as Fulgent Genetics’s financial health and performance track record. I highly recommend you dive deeper by considering the following:

  1. Future Outlook: What are well-informed industry analysts predicting for FLGT’s future growth? Take a look at our free research report of analyst consensus for FLGT’s outlook.
  2. Financial Health: Are FLGT’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.